HAE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $104.68

Capitalizzazione di Mercato (MRQ) $4.76B

P/E (TTM) 50.6

EPS (TTM) $2.07

Ricavi (TTM) $1.35B

ROE (TTM) 11.2%

D/E Debito/Patrimonio (MRQ) 1.4

Intervallo 52 sett. $48–$110

HAE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Split azionari 2

Data ex-dividendo	Split	Tipo
03 Dicembre 2012	2-for-1	Avanti
11 Gennaio 1993	2-for-1	Avanti

Informazioni su Haemonetics Corporation Common Stock Panoramica della società da Wikipedia

05 · wikidata

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.

History

The company was founded in 1971. Haemonetics started out producing the containers and bags required for blood collection. The Latham Bowl was a disposable container that could automate the separation of blood by centrifugation. Through the 90's, the company added additional product lines and technologies. The company opened a manufacturing facility in Holbrook, Massachusetts in 1988.

In 1995 the company purchased the Intravenous Solutions manufacturing facility in Union, South Carolina.

Additional acquisitions grew the company and expanded its services. In the following years the company branched off to making the whole plasma collection station including the machine, supplies and software for plasma collection. These acquisitions included Edmonton-based Fifth Dimension (5D) Information Systems to gain entry into the blood and plasma software industry. Further acquisitions include Chicago-based Arryx in July 2006, Information Data Management, Inc. in January 2007, the acquisition of a division of Haemoscope in 2007, the acquisition of Infonale in July 2007, and, in 2009, Chico, California-based Altivation and Tucson, Arizona-based Sebra.

On August 21, 2007, 5D and IDM were officially merged into a new subsidiary called Haemonetics Software Solutions. The employees at both Edmonton (5D) and Rosemont (IDM) continue to work from their respective offices.

Further acquisitions included the April 2009 acquisition of Neoteric Technology Ltd and the April 2010 acquisition of California-based Global Med Technologies, Inc. Haemonetics acquired the Pall Corporation's transfusion medicine business on August 1, 2012 for ~$550 million.

In April 2024, it was announced Haemonetics had completed its acquisition of the Chicago-headquartered medical device temperature regulation manufacturer, Attune Medical for $160 million.

Product categories

Haemonetics products can be considered as belonging to two broad categories. Donor products (marketed to the blood donation industry, these include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit); and products that are marketed to the surgical suite for blood loss management for patients. These products include surgical blood salvage (or "autotransfusion") devices, surgical field blood suction systems, and blood and patient warming systems.

Hemostasis

TEG 5000

Kaolin TEG

Kaolin TEG with Heparinase

RapidTEG

TEG Functional Fibrinogen

TEG PlateletMapping

TEG 6S

Leggi di più Mostra meno

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

settoreHealth Care industriaHealth Care dipendenti3.009 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$1.33B

2017-04-01 → 2026-03-28

EPS$2.05

2017-04-01 → 2026-03-28

Flusso di cassa libero$260M

2017-04-01 → 2026-03-28

Margine netto7.1%

2017-04-01 → 2026-03-28

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	50.6media 5 anni ≈39.1	≈39.1	28.6	Sopravvalutato
P/S (TTM)	3.5media 5 anni ≈2.8	≈2.8	2.6	Valore equo
P/B (MRQ)	5.7media 5 anni ≈4.2	≈4.2	2.1	Sopravvalutato
EV / EBITDA	36.5media 5 anni ≈29.3	≈29.3	17.9	Sopravvalutato
Prezzo / FCF (TTM)	16.3media 5 anni ≈27.4	≈27.4	·	·
Prezzo / Flusso di cassa (TTM)	14.5media 5 anni ≈16.6	≈16.6	17.6	Sottovalutato
EV / Revenue (EV / Ricavi)	4.3media 5 anni ≈3.4	≈3.4	·	·
EV / FCF	21.9media 5 anni ≈32.5	≈32.5	·	·
Prezzo / Valore contabile tangibile (MRQ)	11.8	·	·	·
PEG Ratio	≈8.8	·	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
Margine lordo (TTM)	59.0%media 5 anni ≈54.1%	≈54.1%	55.0%	In linea
Margine Operativo (TTM)	11.9%media 5 anni ≈12.4%	≈12.4%	14.5%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	11.8%media 5 anni ≈12.4%	≈12.4%	17.6%	In linea
Margine ante imposte (TTM)	9.6%media 5 anni ≈11.1%	≈11.1%	13.1%	In linea
Margine di Profitto Netto (TTM)	7.1%media 5 anni ≈8.6%	≈8.6%	9.5%	In linea
ROA (TTM)	4.0%media 5 anni ≈5.1%	≈5.1%	3.5%	In linea
ROE (TTM)	11.2%media 5 anni ≈12.8%	≈12.8%	6.5%	Di prim'ordine
ROIC	5.9%media 5 anni ≈6.7%	≈6.7%	5.1%	Di prim'ordine

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	1.4media 5 anni ≈1.2	≈1.2	0.4	Debito elevato
Rapporto corrente (MRQ)	3.1media 5 anni ≈2.4	≈2.4	2.7	Liquidità elevata
Quick Ratio	1.6media 5 anni ≈1.3	≈1.3	1.4	Liquidità elevata
Debito a lungo termine / Patrimonio netto (MRQ)	1.4media 5 anni ≈1.0	≈1.0	0.4	Debito elevato

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-2.0%media 5 anni ≈9.2%	≈9.2%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	4.5%media 5 anni ≈10.0%	≈10.0%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	8.9%	·	·	·
EPS YoY	-38.1%media 5 anni ≈25.9%	≈25.9%	·	·
Net Income YoY (Utile Netto YoY)	-42.0%media 5 anni ≈24.6%	≈24.6%	·	·
EPS CAGR 3Y (CAGR EPS 3 anni)	-2.9%media 5 anni ≈23.0%	≈23.0%	·	·
EPS CAGR 5Y (CAGR EPS 5 anni)	5.8%	·	·	·
Net Income CAGR 3Y (CAGR Utile Netto 3 anni)	-5.5%media 5 anni ≈21.8%	≈21.8%	·	·
Net Income CAGR 5Y (CAGR Utile Netto 5 anni)	4.1%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$2.05media 5 anni ≈$2.15	≈$2.15	·	·
Revenue / Share (Ricavi / Azione)	$28.17media 5 anni ≈$24.51	≈$24.51	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$6.19media 5 anni ≈$4.40	≈$4.40	·	·
Cash / Share (Liquidità / Azione)	$5.42media 5 anni ≈$5.20	≈$5.20	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	HAE	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.6media 5 anni ≈0.6	≈0.6	0.6	Debole
Inventory Turnover (Rotazione delle scorte)	1.6media 5 anni ≈1.8	≈1.8	2.9	Debole
Receivables Turnover (Rotazione dei crediti)	6.4media 5 anni ≈6.7	≈6.7	6.4	In linea
Revenue / Employee (Ricavi / Dipendente)	≈$443.3K	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 5.0%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2027	Ago 5, 2026	$1.14	$1.09	4.8%
30 Giugno 2026		$1.14	$1.09	4.8%
31 Marzo 2026		$1.29	$1.28	0.42%
31 Dicembre 2025		$1.31	$1.26	3.7%
30 Settembre 2025		$1.27	$1.12	13.3%
30 Giugno 2025		$1.10	$1.03	7.2%
31 Marzo 2025		$1.24	$1.23	0.62%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	$1.33B	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M
Cost of Revenue	$546M	$612M	$618M	$554M	$488M	$473M	$504M	$550M	$492M	$508M	$503M	$476M
Gross Profit	$788M	$749M	$692M	$615M	$506M	$398M	$485M	$418M	$412M	$378M	$406M	$434M
R&D Expense	$60M	$63M	$54M	$50M	$47M	$33M	$31M	$36M	$39M	$38M	$45M	$54M
SG&A Expense	$442M	$437M	$430M	$377M	$340M	$275M	$282M	$273M	$317M	$302M	$317M	$337M
Operating Expenses	$631M	$527M	$527M	$459M	$425M	$308M	$381M	$334M	$356M	$398M	$450M	$394M
Operating Income	$157M	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M
Other Non-op	$-29M	$-10M	$-13M	$-15M	$-17M	$-17M	$-16M	$-10M	$-5M	$-8M	$-9M	$-9M
Pretax Income	$128M	$212M	$152M	$141M	$64M	$73M	$87M	$74M	$60M	$-27M	$-53M	$31M
Income Tax	$31M	$44M	$34M	$26M	$20M	$-7M	$11M	$19M	$14M	$-1M	$2M	$14M
Net Income	$97M	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M
EPS (Basic)	$2.06	$3.33	$2.32	$2.27	$0.85	$1.57	$1.51	$1.07	$0.86	$-0.51	$-1.09	$0.33
EPS (Diluted)	$2.05	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32
Shares (Basic)	47,179,000	50,330,000	50,706,000	50,783,000	51,047,000	50,688,000	50,692,000	51,533,000	52,755,000	51,524,000	50,910,000	51,533,000
Shares (Diluted)	47,354,000	50,730,000	51,397,000	51,420,000	51,353,000	51,292,000	51,815,000	52,942,000	53,501,000	51,524,000	50,910,000	52,089,000
EBITDA	$157M	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	$-19M	$-44M	$41M

Stato Patrimoniale 25

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	$245M	$307M	$179M	$284M	$259M	$192M	$137M	$169M	$180M	$140M	$115M	$161M
Receivables	$217M	$203M	$207M	$179M	$159M	$128M	$165M	$185M	$151M	$153M	$157M	$146M
Inventory	$306M	$365M	$317M	$259M	$293M	$323M	$270M	$194M	$161M	$177M	$187M	$211M
Prepaid Expense	$66M	$60M	$66M	$47M	$44M	$51M	$31M	$27M	$29M	$41M	$29M	$40M
Current Assets	$835M	$935M	$769M	$770M	$756M	$694M	$604M	$576M	$521M	$510M	$488M	$558M
PP&E (Net)	$306M	$284M	$311M	$311M	$258M	$218M	$253M	$344M	$332M	$324M	$338M	$322M
PP&E (Gross)	$842M	$837M	$959M	$944M	$869M	$817M	$832M	$933M	$873M	$807M	$786M	$732M
Accum. Depreciation	$536M	$553M	$648M	$633M	$611M	$600M	$579M	$589M	$541M	$484M	$449M	$410M
Goodwill	$656M	$604M	$565M	$466M	$467M	$466M	$211M	$211M	$211M	$211M	$268M	$334M
Intangibles	$448M	$456M	$406M	$276M	$310M	$365M	$133M	$128M	$157M	$178M	$204M	$245M
Other Non-current Assets	$142M	$164M	$136M	$107M	$63M	$71M	$62M	$12M	$12M	$12M	$14M	$11M
Total Assets	$2.40B	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B
Accounts Payable	$51M	$67M	$73M	$64M	$58M	$50M	$51M	$63M	$55M	$43M	$40M	$48M
Current Liabilities	$283M	$578M	$300M	$252M	$442M	$253M	$275M	$236M	$385M	$211M	$186M	$189M
Capital Leases	$41M	$50M	$58M	$56M	$56M	$63M	$52M	·	·	·	·	·
Deferred Tax	$38M	$63M	$63M	$36M	$29M	$44M	$11M	$20M	$7M	$12M	$21M	$33M
Other Non-current Liabilities	$59M	$68M	$75M	$75M	$80M	$100M	$89M	$29M	$34M	$22M	$26M	$32M
Long-term Debt	$1.24B	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$316M	$408M	$430M
Total Debt	$1.22B	$1.22B	$808M	$766M	$774M	$708M	$382M	$350M	$254M	$315M	$408M	$428M
Common Stock	$453.0K	$482.0K	$508.0K	$504.0K	$511.0K	$509.0K	$503.0K	$510.0K	$523.0K	$523.0K	$509.0K	$517.0K
Retained Earnings	$279M	$352M	$360M	$253M	$202M	$158M	$79M	$161M	$267M	$290M	$316M	$420M
AOCI	$-38M	$-55M	$-36M	$-30M	$-26M	$-30M	$-45M	$-30M	$-19M	$-33M	$-35M	$-22M
Stockholders' Equity	$796M	$821M	$960M	$818M	$749M	$732M	$587M	$668M	$752M	$740M	$722M	$826M
Liabilities + Equity	$2.40B	$2.45B	$2.20B	$1.93B	$1.86B	$1.82B	$1.27B	$1.27B	$1.24B	$1.24B	$1.32B	$1.49B
Shares Outstanding	45,252,667	48,215,899	50,787,859	50,448,519	51,124,240	50,868,820	50,322,930	51,019,918	52,342,965	52,255,495	50,932,348	51,670,969

Flusso di cassa 16

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
D&A	$112M	$116M	$97M	$93M	$98M	$84M	$110M	$109M	$89M	$90M	$90M	$86M
Stock-based Comp	$34M	$30M	$28M	$26M	$24M	$26M	$20M	$17M	$13M	$9M	$7M	$14M
Deferred Tax	$-26M	$-6M	$-11M	$6M	$5M	$-21M	$-7M	$13M	$-6M	$-7M	$-1M	$4M
Amort. of Intangibles	$50M	$56M	$41M	$42M	$57M	$41M	$34M	$25M	$32M	$37M	$59M	$34M
Restructuring	$3M	$14M	$14M	$657.0K	$4M	$1M	$4M	$395.0K	$31M	$22M	$23M	$37M
Operating Cash Flow	$293M	$182M	$182M	$273M	$172M	$109M	$158M	$159M	$220M	$160M	$122M	$127M
CapEx	$33M	$39M	$38M	$191M	$97M	$37M	$49M	$119M	$75M	$76M	$102M	$122M
Investing Cash Flow	$-180M	$-162M	$-322M	$-144M	$-86M	$-425M	$-57M	$-116M	$-63M	$-73M	$-105M	$-122M
Debt Issued	·	·	·	·	·	·	$0	$348M	$0	$0	·	$0
Net Debt Issued	·	$-5M	$-12M	$-10M	$-18M	$-22M	$-13M	$81M	$-62M	$-43M	$-21M	$-9M
Stock Repurchased	$175M	$225M	$0	$75M	$0	$0	$175M	$160M	$100M	$0	$61M	$39M
Net Stock Activity	$-175M	$-225M	$0	$-75M	$0	$0	$-175M	$-160M	$-100M	$0	$-61M	$-39M
Financing Cash Flow	$-178M	$109M	$38M	$-100M	$-16M	$367M	$-131M	$-51M	$-121M	$-60M	$-63M	$-33M
Net Change in Cash	$-61M	$128M	$-106M	$25M	$67M	$55M	$-32M	$-11M	$41M	$24M	$-46M	$-32M
Taxes Paid	$61M	·	·	·	·	$12M	$12M	$8M	$9M	$7M	$8M	$11M
Free Cash Flow	$260M	$142M	$115M	$163M	$76M	$72M	$109M	$40M	$146M	$84M	$19M	$5M

Redditività 8

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Gross Margin	59.0%	55.0%	52.8%	52.6%	50.9%	45.7%	49.0%	43.1%	45.6%	42.7%	44.7%	47.7%
Operating Margin	11.8%	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%
Net Margin	7.3%	12.3%	9.0%	9.9%	4.4%	9.1%	7.7%	5.7%	5.0%	-3.0%	-6.1%	1.9%
Pretax Margin	9.6%	15.6%	11.6%	12.1%	6.4%	8.4%	8.8%	7.6%	6.6%	-3.1%	-5.9%	3.4%
EBITDA Margin	11.8%	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%
ROA	4.0%	7.2%	5.7%	6.1%	2.4%	5.1%	6.0%	4.4%	3.7%	-2.1%	-4.0%	1.1%
ROE	11.8%	19.4%	12.3%	14.5%	5.9%	11.0%	13.2%	8.7%	6.1%	-3.6%	-7.2%	2.0%
ROIC	5.9%	8.6%	7.2%	8.0%	3.6%	6.8%	9.4%	6.1%	4.3%	-1.8%	-4.0%	1.8%

Liquidità e Solvibilità 4

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Current Ratio	3.0	1.6	2.6	3.1	1.7	2.7	2.2	2.4	1.4	2.4	2.6	3.0
Quick Ratio	1.6	0.9	1.3	1.8	0.9	1.3	1.1	1.5	0.9	1.4	1.5	1.6
Debt / Equity	1.5	1.5	0.8	0.9	1.0	1.0	0.7	0.5	0.3	0.4	0.6	0.5
LT Debt / Equity	1.5	1.1	0.8	0.9	0.7	0.9	0.5	0.5	0.1	0.3	0.5	0.5

Efficienza 3

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Asset Turnover	0.6	0.6	0.6	0.6	0.5	0.6	0.8	0.8	0.7	0.7	0.6	0.6
Inventory Turnover	1.6	1.8	2.1	2.0	1.6	1.6	2.2	3.1	2.9	2.8	2.5	2.3
Receivables Turnover	6.4	6.7	6.8	6.9	6.9	5.9	5.6	5.8	5.9	5.7	6.0	5.9

Per Azione 5

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Book Value / Share	$17.60	$17.02	$18.90	$16.21	$14.66	$14.38	$11.67	$13.09	$14.38	$14.15	$14.17	$15.99
Revenue / Share	$28.17	$26.82	$25.47	$22.73	$19.34	$16.97	$19.08	$18.28	$16.90	$17.20	$17.85	$17.48
Cash Flow / Share	$6.19	$3.58	$3.54	$5.31	$3.35	$2.12	$3.05	$3.01	$4.12	$3.10	$2.39	$2.44
Cash / Share	$5.42	$6.36	$3.52	$5.64	$5.08	$3.78	$2.73	$3.32	$3.44	$2.67	$2.26	$3.11
EPS (TTM)	$2.05	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32

Tassi di Crescita 9

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue YoY	-2.0%	4.0%	12.0%	17.7%	14.1%	·	·	·	·	·	·	·
Revenue CAGR 3Y	4.5%	11.1%	14.6%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	8.9%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-38.1%	44.5%	2.2%	166.7%	-45.8%	·	·	·	·	·	·	·
EPS CAGR 3Y	-2.9%	58.0%	13.9%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	5.8%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-42.0%	42.6%	1.9%	166.1%	-45.4%	·	·	·	·	·	·	·
Net Income CAGR 3Y	-5.5%	56.9%	13.9%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	4.1%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue TTM	$1.33B	$1.36B	$1.31B	$1.17B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M
Net Income TTM	$97M	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	$-26M	$-56M	$17M
Market Cap	$2.45B	$3.05B	$4.33B	$4.17B	$3.26B	$5.70B	$5.08B	$4.46B	$3.83B	$2.12B	$1.80B	$2.28B
Enterprise Value	$3.42B	$3.96B	$4.96B	$4.66B	$3.78B	$6.21B	$5.33B	$4.64B	$3.90B	$2.30B	$2.09B	$2.55B
P/E	26.4	19.1	37.3	36.9	76.0	72.3	68.2	84.1	86.1	-79.5	-32.4	138.2
P/S	1.8	2.2	3.3	3.6	3.3	6.5	5.1	4.6	4.2	2.4	2.0	2.5
P/B	3.1	3.7	4.5	5.1	4.4	7.8	8.7	6.7	5.1	2.9	2.5	2.8
P / Tangible Book	·	·	·	54.9	·	·	·	·	·	·	·	·
P / Cash Flow	8.3	16.8	23.8	15.3	18.9	52.4	32.1	28.0	17.4	13.3	14.7	18.0
P / FCF	9.4	21.4	37.5	25.6	43.1	79.4	46.4	110.7	26.3	25.4	92.4	460.7
EV / EBITDA	21.8	17.9	30.1	29.8	46.8	69.2	51.5	55.6	69.5	-118.4	-47.6	62.9
EV / FCF	13.1	27.8	43.0	28.6	49.9	86.6	48.7	115.2	26.8	27.5	107.4	514.6
EV / Revenue	2.6	2.9	3.8	4.0	3.8	7.1	5.4	4.8	4.3	2.6	2.3	2.8
Earnings Yield	3.8%	5.2%	2.7%	2.7%	1.3%	1.4%	1.5%	1.2%	1.2%	-1.3%	-3.1%	0.72%

Conto Economico 16

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Revenue	$339M	$346M	$339M	$327M	$321M	$331M	$349M	$346M	$336M	$343M	$336M	$318M	$340M	$305M	$297M
Cost of Revenue	$137M	$148M	$137M	$133M	$129M	$138M	$155M	$158M	$161M	$167M	$158M	$148M	$169M	$147M	$140M
Gross Profit	$203M	$198M	$202M	$195M	$192M	$193M	$194M	$187M	$175M	$176M	$178M	$171M	$172M	$159M	$158M
R&D Expense	$16M	$14M	$14M	$15M	$16M	$18M	$16M	$14M	$14M	$16M	$13M	$13M	$16M	$13M	$11M
SG&A Expense	$119M	$121M	$109M	$102M	$111M	$115M	$106M	$107M	$108M	$109M	$112M	$115M	$98M	$95M	$92M
Operating Expenses	$145M	$221M	$135M	$136M	$138M	$122M	$135M	$136M	$135M	$146M	$132M	$135M	$121M	$115M	$111M
Operating Income	$57M	$-23M	$67M	$58M	$54M	$71M	$59M	$52M	$40M	$30M	$46M	$35M	$51M	$43M	$47M
Other Non-op	$-10M	$-5M	$-7M	$-7M	$-9M	$-598.0K	$-9M	$-7M	$7M	$-7M	$-2M	$-2M	$-3M	$-1M	$-6M
Pretax Income	$48M	$-28M	$60M	$51M	$45M	$71M	$50M	$45M	$47M	$23M	$44M	$33M	$48M	$42M	$41M
Income Tax	$15M	$-8M	$15M	$13M	$11M	$13M	$12M	$11M	$8M	$3M	$13M	$8M	$5M	$9M	$8M
Net Income	$33M	$-20M	$45M	$39M	$34M	$58M	$37M	$34M	$38M	$20M	$31M	$25M	$42M	$33M	$33M
EPS (Basic)	$0.73	$-0.42	$0.96	$0.81	$0.71	$1.17	$0.75	$0.66	$0.75	$0.40	$0.62	$0.49	$0.84	$0.65	$0.65
EPS (Diluted)	$0.72	$-0.41	$0.95	$0.81	$0.70	$1.17	$0.74	$0.66	$0.74	$0.40	$0.61	$0.48	$0.84	$0.64	$0.64
Shares (Basic)	45,361,000	·	46,792,000	47,590,000	48,111,000	·	50,286,000	50,898,000	50,943,000	·	50,768,000	50,727,000	·	50,509,000	50,953,000
Shares (Diluted)	45,704,000	·	46,987,000	47,664,000	48,353,000	·	50,639,000	51,240,000	51,564,000	·	51,445,000	51,396,000	·	51,219,000	51,558,000
EBITDA	$57M	·	$67M	$58M	$54M	·	$59M	$52M	$40M	·	$46M	$35M	·	$43M	$47M

Stato Patrimoniale 25

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Cash & Equivalents	$223M	$245M	$363M	$296M	$293M	$307M	$321M	$299M	$344M	$179M	$194M	$351M	·	$224M	$241M
Receivables	$216M	$217M	$196M	$207M	$201M	$203M	$212M	$214M	$201M	$207M	$212M	$174M	·	$181M	$172M
Inventory	$307M	$306M	$321M	$336M	$361M	$365M	$360M	$382M	$374M	$317M	$304M	$286M	·	$256M	$255M
Prepaid Expense	$65M	$66M	$63M	$60M	$59M	$60M	$113M	$61M	$59M	$66M	$55M	$55M	·	$45M	$48M
Current Assets	$811M	$835M	$944M	$900M	$913M	$935M	$1.01B	$956M	$979M	$769M	$765M	$866M	·	$706M	$716M
PP&E (Net)	$304M	$306M	$297M	$292M	$287M	$284M	$286M	$300M	$302M	$311M	$319M	$308M	·	$313M	$308M
PP&E (Gross)	$854M	$842M	$837M	$815M	$795M	$837M	$867M	$939M	$949M	$959M	$979M	$950M	·	·	·
Accum. Depreciation	$550M	$536M	$540M	$523M	$508M	$553M	$581M	$639M	$647M	$648M	$661M	$642M	·	·	·
Goodwill	$657M	$656M	$607M	$606M	$607M	$604M	$605M	$616M	$613M	$565M	$555M	$465M	$466M	$466M	$465M
Intangibles	$435M	$448M	$420M	$428M	$451M	$456M	$466M	$488M	$495M	$406M	$429M	$251M	·	$284M	$293M
Other Non-current Assets	$150M	$142M	$216M	$208M	$196M	$164M	$160M	$156M	$142M	$136M	$127M	$117M	·	$103M	$80M
Total Assets	$2.37B	$2.40B	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	·	$1.88B	$1.87B
Accounts Payable	$56M	$51M	$49M	$62M	$46M	$67M	$63M	$69M	$77M	$73M	$57M	$80M	·	$64M	$61M
Current Liabilities	$263M	$283M	$540M	$548M	$531M	$578M	$253M	$274M	$260M	$300M	$262M	$264M	·	$227M	$262M
Capital Leases	·	$41M	·	·	·	$50M	·	·	·	$58M	·	·	·	·	·
Deferred Tax	$39M	$38M	$56M	$58M	$59M	$63M	$61M	$63M	$65M	$63M	$62M	$35M	·	$40M	$36M
Other Non-current Liabilities	$57M	$59M	$64M	$66M	$68M	$68M	$90M	$90M	$92M	$75M	$76M	$70M	·	$78M	$78M
Long-term Debt	$1.19B	$1.24B	$1.22B	$1.22B	$1.22B	$1.25B	$1.22B	$1.22B	$1.22B	$808M	$871M	$762M	·	$767M	$818M
Total Debt	$1.17B	·	$1.22B	$1.22B	$1.22B	·	$1.22B	$1.22B	$1.22B	·	$871M	$762M	·	$767M	$818M
Common Stock	$455.0K	$453.0K	$468.0K	$467.0K	$482.0K	$482.0K	$502.0K	$504.0K	$512.0K	$508.0K	$508.0K	$507.0K	·	$504.0K	$506.0K
Retained Earnings	$312M	$279M	$381M	$336M	$356M	$352M	$392M	$369M	$387M	$360M	$340M	$309M	·	$224M	$204M
AOCI	$-42M	$-38M	$-35M	$-41M	$-36M	$-55M	$-56M	$-35M	$-43M	$-36M	$-24M	$-33M	·	$-36M	$-40M
Stockholders' Equity	$837M	$796M	$911M	$849M	$882M	$821M	$907M	$879M	$905M	$960M	$943M	$894M	$818M	$776M	$729M
Liabilities + Equity	$2.37B	$2.40B	$2.49B	$2.44B	$2.46B	$2.45B	$2.53B	$2.53B	$2.54B	$2.20B	$2.20B	$2.01B	·	$1.88B	$1.87B
Shares Outstanding	45,471,313	45,252,667	46,829,249	46,747,381	48,158,723	48,215,899	50,235,051	50,381,127	51,152,886	50,787,859	50,785,040	50,740,389	·	50,444,470	50,605,499

Flusso di cassa 13

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
D&A	$27M	$27M	$27M	$28M	$29M	$28M	$29M	$29M	$29M	$28M	$24M	·	$24M	$24M	·
Stock-based Comp	$9M	$9M	$8M	$8M	$9M	$7M	$8M	$7M	$8M	$7M	$7M	·	$7M	$7M	·
Deferred Tax	$668.0K	$-20M	$-2M	$-725.0K	$-3M	$3M	$-2M	$-2M	$-4M	$-6M	$-3M	·	·	·	·
Amort. of Intangibles	$12M	$12M	$12M	$13M	$13M	$13M	$14M	$14M	$14M	$13M	$9M	$9M	$15M	$10M	$11M
Restructuring	$2M	$196.0K	$1M	$204.0K	$1M	$984.0K	$4M	$5M	$5M	$6M	$8M	$86.0K	$701.0K	$44.0K	$165.0K
Operating Cash Flow	$52M	$71M	$94M	$111M	$17M	$117M	$44M	$49M	$-27M	$64M	$-540.0K	·	$80M	$64M	·
CapEx	$8M	$18M	$6M	$5M	$4M	$16M	$9M	$9M	$6M	$7M	$-3M	·	$93M	$17M	·
Investing Cash Flow	$-22M	$-87M	$-29M	$-30M	$-33M	$18M	$-17M	$-23M	$-139M	$-13M	$-269M	·	$-18M	$-36M	·
Net Debt Issued	$-2M	·	·	·	$-2M	·	·	·	$-2M	·	·	·	·	·	·
Stock Repurchased	·	$100M	$0	·	·	$150M	$0	·	·	$0	$0	·	$0	$0	·
Financing Cash Flow	$-52M	$-101M	$2M	$-77M	$-2M	$-151M	$1M	$-75M	$334M	$-64M	$109M	·	$-2M	$-50M	·
Net Change in Cash	$-22M	$-118M	$67M	$4M	$-14M	$-14M	$22M	$-45M	$166M	$-15M	$-157M	·	$60M	$-17M	·
Free Cash Flow	$44M	·	·	·	$14M	·	·	·	$-33M	·	·	·	·	·	·

Redditività 8

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Gross Margin	59.8%	·	59.7%	59.5%	59.8%	·	55.5%	54.2%	52.0%	·	52.9%	53.6%	·	52.0%	53.1%
Operating Margin	16.9%	·	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	·	14.2%	15.7%
Net Margin	9.7%	·	13.2%	11.8%	10.6%	·	10.8%	9.8%	11.4%	·	9.3%	7.8%	·	10.8%	11.2%
Pretax Margin	14.0%	·	17.7%	15.7%	14.1%	·	14.3%	12.9%	13.9%	·	13.1%	10.3%	·	13.8%	13.8%
EBITDA Margin	16.9%	·	19.9%	17.9%	16.8%	·	16.9%	15.0%	11.8%	·	13.7%	11.1%	·	14.2%	15.7%
ROA	1.4%	·	1.8%	1.6%	1.4%	·	1.6%	1.5%	1.7%	·	1.5%	1.3%	·	1.8%	1.8%
ROE	3.8%	·	4.9%	4.5%	3.8%	·	4.0%	3.8%	4.3%	·	3.6%	3.1%	·	4.4%	4.7%
ROIC	2.0%	·	2.4%	2.1%	1.9%	·	2.1%	1.9%	1.5%	·	1.8%	1.6%	·	2.2%	2.4%

Liquidità e Solvibilità 4

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Current Ratio	3.1	·	1.7	1.6	1.7	·	4.0	3.5	3.8	·	2.9	3.3	·	3.1	2.7
Quick Ratio	1.7	·	1.0	0.9	0.9	·	2.1	1.9	2.1	·	1.5	2.0	·	1.8	1.6
Debt / Equity	1.4	·	1.3	1.4	1.4	·	1.4	1.4	1.4	·	0.9	0.9	·	1.0	1.1
LT Debt / Equity	1.4	·	1.0	1.1	1.0	·	1.3	1.4	1.3	·	0.9	0.8	·	1.0	1.0

Efficienza 3

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Asset Turnover	0.1	·	0.1	0.1	0.1	·	0.1	0.2	0.1	·	0.2	0.2	·	0.2	0.2
Inventory Turnover	0.4	·	0.4	0.4	0.4	·	0.5	0.5	0.5	·	0.6	0.5	·	0.5	0.5
Receivables Turnover	1.6	·	1.7	1.6	1.6	·	1.6	1.8	1.8	·	1.7	1.8	·	1.8	1.9

Per Azione 5

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Book Value / Share	$18.41	·	$19.46	$18.17	$18.32	·	$18.05	$17.44	$17.70	·	$18.57	$17.61	·	$15.38	$14.41
Revenue / Share	$7.43	·	$7.21	$6.87	$6.65	·	$6.88	$6.74	$6.52	·	$6.54	$6.19	·	$5.96	$5.77
Cash Flow / Share	$1.14	·	·	·	$0.36	·	·	·	$-0.53	·	·	·	·	·	·
Cash / Share	$4.91	·	$7.76	$6.34	$6.08	·	$6.39	$5.94	$6.73	·	$3.82	$6.92	·	$4.44	$4.77
EPS (TTM)	$2.07	·	$3.63	$3.42	$3.27	·	$2.54	$2.41	$2.23	·	$2.73	$2.76	·	·	·

Valutazione (TTM) 11

Metrica	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q4 2023	Q3 2023	Q2 2023
Revenue TTM	$1.35B	·	$1.32B	$1.33B	$1.35B	·	$1.37B	$1.36B	$1.33B	·	$1.31B	$1.28B	·	·	·
Net Income TTM	$96M	·	$175M	$168M	$163M	·	$130M	$124M	$115M	·	$140M	$141M	·	·	·
Market Cap	$3.51B	·	$3.76B	$2.25B	$3.55B	·	$3.90B	$4.02B	$4.23B	·	$4.34B	$4.55B	·	$3.97B	$3.75B
Enterprise Value	$4.47B	·	$4.62B	$3.18B	$4.49B	·	$4.80B	$4.95B	$5.11B	·	$5.02B	$4.96B	·	$4.51B	$4.32B
P/E	37.3	·	22.1	14.1	22.6	·	30.5	33.1	37.1	·	31.3	32.5	·	·	·
P/S	2.6	·	2.9	1.7	2.6	·	2.8	3.0	3.2	·	3.3	3.6	·	·	·
P/B	4.2	·	4.1	2.7	4.0	·	4.3	4.6	4.7	·	4.6	5.1	·	5.1	5.1
P / Tangible Book	·	·	·	·	·	·	·	·	·	·	·	25.6	·	155.7	·
P / Cash Flow	67.2	·	·	·	204.3	·	·	·	-154.3	·	·	·	·	·	·
EV / Revenue	3.3	·	3.5	2.4	3.3	·	3.5	3.6	3.8	·	3.8	3.9	·	·	·
Earnings Yield	2.7%	·	4.5%	7.1%	4.4%	·	3.3%	3.0%	2.7%	·	3.2%	3.1%	·	·	·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Ricavi	$1.33B	$1.36B	$1.31B	$1.17B	$993M
Margine Lordo %	59.0%	55.0%	52.8%	52.6%	50.9%
Margine Operativo %	11.8%	16.3%	12.6%	13.4%	8.1%
Utile netto	$97M	$168M	$118M	$115M	$43M
EPS Diluito	$2.05	$3.31	$2.29	$2.24	$0.84

Metrica	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Debito / Patrimonio Netto	1.5	1.5	0.8	0.9	1.0
Rapporto corrente	3.0	1.6	2.6	3.1	1.7
Quick Ratio	1.6	0.9	1.3	1.8	0.9

Metrica	2026-03-28	2025-03-29	2024-03-30	2023-04-01	2022-04-02
Flusso di cassa libero	$260M	$142M	$115M	$163M	$76M

Proprietari istituzionali (13F) 361 filer · $4.0B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 361

Valore detenuto $4.0B

Nuove posizioni 57

Posizioni chiuse 43

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
57 (-3 vs trimestre precedente)	43 (-12 vs trimestre precedente)	108 (-8 vs trimestre precedente)	122 (+10 vs trimestre precedente)	+2.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$443.194.350	5.909.258	11,13%	Azioni
VANGUARD GROUP INC	$381.604.971	4.761.135	9,58%	Azioni
NEUBERGER BERMAN GROUP LLC	$313.473.399	4.179.443	7,87%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$190.979.550	2.546.394	4,79%	Azioni
AQR CAPITAL MANAGEMENT LLC	$165.023.065	2.266.489	4,14%	Azioni
ARIEL INVESTMENTS, LLC	$154.572.450	2.060.966	3,88%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$154.468.350	2.059.578	3,88%	Azioni
STATE STREET CORP	$136.363.950	1.818.186	3,42%	Azioni
DIMENSIONAL FUND ADVISORS LP	$118.892.744	1.585.222	2,98%	Azioni
CITADEL ADVISORS LLC	$113.259.000	1.510.120	2,84%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$96.559.855	1.287.240	2,42%	Azioni
River Road Asset Management, LLC	$96.420.150	1.285.602	2,42%	Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$86.651.325	1.155.351	2,18%	Azioni
GOLDMAN SACHS GROUP INC	$78.451.463	1.046.019	1,97%	Azioni
UBS Group AG	$73.753.350	983.378	1,85%	Azioni
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/	$62.319.375	830.925	1,56%	Azioni
ROYAL BANK OF CANADA	$58.518.000	780.248	1,47%	Azioni
Allspring Global Investments Holdings, LLC	$57.269.232	765.120	1,44%	Azioni
DEUTSCHE BANK AG\	$47.374.725	631.663	1,19%	Azioni
NORTHERN TRUST CORP	$47.365.650	631.542	1,19%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$44.356.725	591.423	1,11%	Azioni
Boston Trust Walden Corp	$43.886.100	585.148	1,10%	Azioni
MILLENNIUM MANAGEMENT LLC	$42.780.975	570.413	1,07%	Azioni
Holocene Advisors, LP	$41.264.625	550.195	1,04%	Azioni
SILVERCREST ASSET MANAGEMENT GROUP LLC	$37.034.909	493.796	0,93%	Azioni
MORGAN STANLEY	$34.961.254	466.149	0,88%	Azioni
BANK OF AMERICA CORP /DE/	$33.326.325	444.351	0,84%	Azioni
Boston Partners	$30.395.842	405.892	0,76%	Azioni
FRANKLIN RESOURCES INC	$26.060.960	347.479	0,65%	Azioni
North Peak Capital Management, LLC	$25.730.775	343.077	0,65%	Azioni
LONDON CO OF VIRGINIA	$25.543.299	340.574	0,64%	Azioni
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	$24.905.625	332.075	0,63%	Azioni
VANGUARD FIDUCIARY TRUST CO	$24.779.850	330.398	0,62%	Azioni
CITIGROUP INC	$24.002.775	320.037	0,60%	Azioni
Aristotle Capital Boston, LLC	$21.721.809	289.624	0,55%	Azioni
FMR LLC	$21.604.051	288.054	0,54%	Azioni
Bank of New York Mellon Corp	$21.566.396	287.552	0,54%	Azioni
MIZUHO MARKETS AMERICAS LLC	$21.166.050	282.214	0,53%	Azioni
JPMORGAN CHASE & CO	$17.275.045	227.888	0,43%	Azioni
PRINCIPAL FINANCIAL GROUP INC	$16.493.025	219.907	0,41%	Azioni
Invenomic Capital Management LP	$16.216.275	216.217	0,41%	Azioni
GLENMEDE TRUST CO NA	$15.348.975	204.653	0,39%	Azioni
HEARTLAND ADVISORS INC	$15.000.000	200.000	0,38%	Azioni
Invesco Ltd.	$12.976.425	173.019	0,33%	Azioni
SEI INVESTMENTS CO	$12.546.500	167.274	0,31%	Azioni
Longaeva Partners L.P.	$12.286.650	163.822	0,31%	Azioni
RHUMBLINE ADVISERS	$10.812.225	144.163	0,27%	Azioni
AMERICAN CENTURY COMPANIES INC	$10.613.250	141.510	0,27%	Azioni
JANUS HENDERSON GROUP PLC	$10.491.810	186.163	0,26%	Azioni
Nuveen, LLC	$10.435.425	139.139	0,26%	Azioni

Mostra tutti i 361 proprietari istituzionali →

Attivisti e proprietari del 5%+ 8 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	06 Febbraio 2004	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	20 Agosto 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	08 Agosto 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	24 Giugno 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	19 Giugno 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	03 Giugno 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	27 Maggio 2003	·	Deposito iniziale	·	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata	15 Giugno 2001	·	Deposito iniziale	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 72 insider · 48 dirigenti · 25 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Netto 12m
Christopher Simon,	President & CEO	15 Maggio 2026 A	444.704	0	$0
Brian Concannon	President & CEO	15 Settembre 2015 M	147.040	0	$0
James Darecca	EVP, Chief Financial Officer	15 Maggio 2026 A	54.444	0	$0
William P. Mr. Burke	EVP, Chief Financial Officer	23 Agosto 2021 M	30.291	0	$0
Christopher J Lindop	CFO & EVP Business Development	13 Gennaio 2016 A	56.743	0	$0
Ronald J Ryan	VP and CFO	01 Novembre 2006 P	2.101	0	$0
Stewart W Strong	President, Global Hospital	26 Luglio 2024 S	18.196	0	$0
Byron Selman	President, Global Markets	25 Ottobre 2016 A	23.318	0	$0
Peter M Allen	President, Global Plasma	06 Luglio 2015 M	34.102	0	$0
Kelly Michael P	President, Global Markets	11 Novembre 2013 M	10.987	0	$0
Mikael Gordon	President, Global Markets	03 Maggio 2012 M	4.442	0	$0
Remi Corlin	President, Asia	08 Agosto 2008 M	884	0	$0
Keiko Hattori	President, Haemonetics Japan	01 Maggio 2008 P	716	0	$0
Thomas Lawlor	President, Patient Division	28 Novembre 2007 M	0	0	$0
Ryoji Sakai	President, Japan	14 Giugno 2007 M	0	0	$0
Ulrich Eckert	President, Europe & Latin Am	01 Novembre 2006 P	890	0	$0
Yutaka Sakurada	President, Japan & Asia	02 Maggio 2005 P	2.347	0	$0
Frank Chan	EVP, Chief Operating Officer	15 Maggio 2026 A	32.936	0	$0
Kent J Davies	Chief Operating Officer	23 Ottobre 2015 S	16.891	0	$0
Farris Maryanne Maunsell	VP, Chief Accounting Officer	05 Giugno 2026 F	6.242	0	$0
Laurie A. Miller	SVP, Human Resources	05 Giugno 2026 F	40.987	0	$0
Roy Galvin	EVP, Chief Commercial Officer	15 Maggio 2026 A	39.882	0	$0
Michelle L Basil	EVP and General Counsel	15 Maggio 2026 A	68.829	0	$0
Anila Lingamneni	EVP, Chief Technology Officer	12 Luglio 2024 S	21.331	0	$0
Josep Llorens	EVP, Global Manufacturing	28 Maggio 2024 F	30.940	0	$0
Dan Goldstein	VP, Corporate Controller	13 Giugno 2022 S	4.447	0	$0
Jacqueline Scanlan	SVP, Global Human Resources	07 Giugno 2021 S	4.216	0	$0
Said Bolorforosh	EVP, Chief Technology Officer	11 Novembre 2019 S	1.977	0	$0
Neil 122-62-507 Ryding	EVP, Global Manufacturing	07 Giugno 2018 S	15.226	0	$0
David Fusco	EVP, Global Human Resources	25 Ottobre 2016 A	16.867	0	$0
Sandra Jesse	EVP and Chief Legal Officer	25 Ottobre 2016 A	48.166	0	$0
Jonathan White	Chief Science and Technology	26 Ottobre 2015 S	30.507	0	$0
Susan M Hanlon	VP Finance	26 Ottobre 2015 S	20.464	0	$0
Brian R Burns	EVP, Global QA/RA	23 Ottobre 2015 S	16.235	0	$0
Dave Helsel	EVP, Global Manufacturing	13 Aprile 2015 D	13.216	0	$0
Kathleen Mcdaniel	EVP Global Human Resources	28 Agosto 2014 S	5.013	0	$0
Warren Nighan JR	EVP, Global QA/RA	24 Luglio 2013 A	7.618	0	$0
Joseph J Forish	VP, Human Resources	30 Aprile 2013 P	17.279	0	$0
Phillip John Brancazio	VP, Global Manufacturing	04 Maggio 2011 P	3.052	0	$0
Alicia R Lopez	VP, Corporate Affairs	05 Aprile 2011 D	2.815	0	$0
Michael I Ruxin	VP Global Software Strategies	04 Novembre 2010 P	215	0	$0
Brad Nutter	Chairman of the Board	29 Luglio 2010 A	10.580	0	$0
Robert B Ebbeling	Vice President, Operations	01 Maggio 2009 P	15.849	0	$0
Jan Conneely	VP & GM, Arryx, Inc.	01 Maggio 2008 P	1.041	0	$0
William Granville	VP, Manufacturing	01 Maggio 2008 P	12.188	0	$0
Mark A Popovsky	VP, Corporate Medical Director	01 Maggio 2008 P	4.891	0	$0
Stephen Swenson	VP & General Mgr, Global Plasm	01 Maggio 2008 P	3.024	0	$0
William Roche Still	VP & Gen Mrg, Therapeutics Bus	04 Maggio 2007 M	4.193	0	$0
Lloyd Emerson Johnson	Direttore	24 Luglio 2026 A	15.471	0	$0
Diane M Bryant	Direttore	24 Luglio 2026 A	9.664	0	$0
Claire Pomeroy	Direttore	24 Luglio 2026 A	19.410	0	$0
Ellen M Zane	Direttore	24 Luglio 2026 A	21.911	0	$0
Martin D Madaus	Direttore	24 Luglio 2026 A	2.538	0	$0
Mark W Kroll	Direttore	24 Luglio 2026 A	27.295	1	$98.784
Michael J Coyle	Direttore	24 Luglio 2026 A	17.932	0	$0
Robert E Abernathy	Direttore	24 Luglio 2026 A	27.519	0	$0
Charles J Dockendorff	Direttore	24 Luglio 2025 A	7.126	0	$0
Catherine M Burzik	Direttore	05 Agosto 2022 A	19.545	0	$0
Richard J Meelia	Direttore	04 Febbraio 2021 M	32.050	0	$0
Ronald G Gelbman	Direttore	11 Novembre 2019 M	48.384	0	$0
Pedro P Granadillo	Direttore	08 Novembre 2018 S	15.335	0	$0
Susan Bartlett Foote	Direttore	10 Novembre 2017 M	20.740	0	$0
Ronald Merriman	Direttore	22 Maggio 2017 M	17.807	0	$0
Lawrence C Best	Direttore	12 Giugno 2014 M	10.001	0	$0
Paul Black	Direttore	24 Luglio 2013 A	8.981	0	$0
Ronald A Matricaria	Direttore	05 Maggio 2006 A	·	0	$0
Benjamin L Holmes	Direttore	31 Gennaio 2005 M	·	0	$0
Donna C E Williamson	Direttore	23 Giugno 2004 M	1.300	0	$0
Harvey G Klein	Direttore	05 Maggio 2004 A	·	0	$0
Anthony Pare	·	30 Giugno 2008 M	2.523	0	$0
James O'Shaughnessy	·	01 Maggio 2008 P	3.781	0	$0
Mark Beucler	·	01 Maggio 2008 P	1.989	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 65 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
JSML · Janus Detroit Street Trust	1,11%	46.966 NS	31 Luglio 2026	N-PORT
JSMD · Janus Detroit Street Trust	0,91%	112.014 NS	31 Luglio 2026	N-PORT
ROSC · Lattice Strategies Trust	0,85%	6.121 NS	31 Luglio 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,37%	14.249 SH	02 Ottobre 2026	Giornaliero
FYC · First Trust Exchange-Traded AlphaDE…	0,31%	46.806 NS	31 Luglio 2026	N-PORT
IWO · iShares Trust	0,30%	419.058 SH	11 Settembre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,27%	68.060 SH	02 Ottobre 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,20%	47.624 SH	19 Agosto 2026	Giornaliero
BKSE · BNY Mellon ETF Trust	0,17%	1.770 NS	31 Luglio 2026	N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr…	0,16%	11.309 NS	31 Luglio 2026	N-PORT
QVMM · Invesco Exchange-Traded Fund Trust …	0,16%	6.183 SH	02 Ottobre 2026	Giornaliero
IWM · iShares Trust	0,16%	1.206.787 SH	11 Settembre 2026	Giornaliero
SMDX · Tidal Trust III	0,15%	2.335 NS	31 Luglio 2026	N-PORT
NUSC · Nushares ETF Trust	0,15%	23.101 NS	31 Luglio 2026	N-PORT
PKW · Invesco Exchange-Traded Fund Trust	0,15%	24.033 SH	02 Ottobre 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,15%	12.150 NS	31 Luglio 2026	N-PORT
FSMD · FIDELITY COVINGTON TRUST	0,15%	43.448 NS	31 Luglio 2026	N-PORT
RSSL · Global X Funds	0,13%	22.588 NS	31 Luglio 2026	N-PORT
IVOG · VANGUARD ADMIRAL FUNDS	0,11%	27.512 SH	19 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,11%	271.486 SH	19 Agosto 2026	Giornaliero
EBIT · Harbor ETF Trust	0,11%	154 NS	31 Luglio 2026	N-PORT
PTMC · Pacer Funds Trust	0,11%	5.030 NS	31 Luglio 2026	N-PORT
ESML · iShares Trust	0,11%	29.599 SH	11 Settembre 2026	Giornaliero
DFAT · Dimensional ETF Trust	0,10%	173.703 NS	31 Luglio 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0,10%	74.976 SH	19 Agosto 2026	Giornaliero
MIDU · Direxion Shares ETF Trust	0,09%	682 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,08%	150.472 NS	31 Luglio 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0,08%	15.968 SH	19 Agosto 2026	Giornaliero
FYX · First Trust Exchange-Traded AlphaDE…	0,07%	11.631 NS	31 Luglio 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,06%	4.239 NS	31 Luglio 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,06%	22.085 NS	31 Luglio 2026	N-PORT
ISCG · iShares Trust	0,06%	5.407 SH	11 Settembre 2026	Giornaliero
RWK · Invesco Exchange-Traded Fund Trust …	0,06%	6.859 SH	02 Ottobre 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,05%	302.003 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,05%	139.826 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,05%	3.039 SH	11 Settembre 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,04%	533.077 SH	19 Agosto 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,04%	1.042.525 SH	19 Agosto 2026	Giornaliero
VBR · VANGUARD INDEX FUNDS	0,04%	331.074 SH	19 Agosto 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,03%	2.112 NS	31 Luglio 2026	N-PORT
DFUV · Dimensional ETF Trust	0,02%	40.194 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,02%	104.425 NS	31 Luglio 2026	N-PORT
DFSU · Dimensional ETF Trust	0,02%	4.745 NS	31 Luglio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,02%	6.430 NS	31 Luglio 2026	N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe…	0,02%	392 SH	02 Ottobre 2026	Giornaliero
DFAU · Dimensional ETF Trust	0,01%	14.641 NS	31 Luglio 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	2.320 SH	19 Agosto 2026	Giornaliero
ESGV · VANGUARD WORLD FUND	0,01%	10.376 SH	19 Agosto 2026	Giornaliero
IUSG · iShares Trust	0,01%	23.921 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,01%	14.081 SH	11 Settembre 2026	Giornaliero
ITOT · iShares Trust	0,01%	61.263 SH	11 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,01%	15.447 NS	31 Luglio 2026	N-PORT
IUSV · iShares Trust	0,01%	16.215 SH	11 Settembre 2026	Giornaliero
TILT · FlexShares Trust	0,00%	948 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.441.997 SH	19 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	37.682 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	3.899 SH	19 Agosto 2026	Giornaliero
IJH · iShares Trust	·	1.630.595 SH	11 Settembre 2026	Giornaliero
IJK · iShares Trust	·	161.240 SH	11 Settembre 2026	Giornaliero
IJJ · iShares Trust	·	94.617 SH	21 Agosto 2026	Giornaliero
IWN · iShares Trust	·	24.317 SH	11 Settembre 2026	Giornaliero
XJH · iShares Trust	·	6.379 SH	08 Settembre 2026	Giornaliero
ISCB · iShares Trust	·	2.011 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	6.131 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	28.971 SH	11 Settembre 2026	Giornaliero

HAE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 15 analisti COMPRA

Target mediano $116.50 +11,3%

5 33,3% Acquisto forte

6 40,0% Compra

4 26,7% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

10 analisti · 2026-10-01

Target medio $111.50 +6,5%

Ora Prezzo attuale $104.68

Basso$86.00 Media$111.50 Alto$125.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
HAE	$2.45B	26.4	-2.0%	7.3%	11.8%	59.0%
COO	$13.70B	37.4	5.1%	9.2%	4.6%	65.5%
ALGN	$11.14B	27.6	0.90%	10.2%	10.3%	67.2%
LNTH	$4.30B	19.5	0.50%	15.2%	20.7%	61.1%
MMED	$3.71B	-10.2	14.2%	-10.7%	-9.3%	54.2%
MMSI	$5.24B	41.4	11.8%	8.5%	8.4%	48.7%
QDEL	$1.99B	-1.8	-1.9%	-41.4%	-48.0%	·
ICUI	$3.52B	4755.7	-6.3%	0.03%	0.03%	36.8%
XRAY	$2.28B	-3.8	-3.0%	-16.2%	-36.4%	50.0%
NEOG	$1.95B	-224.2	-2.7%	-0.91%	-0.38%	46.9%
UFPT	$1.71B	25.4	19.5%	11.3%	16.9%	28.3%

Ultime notizie Notizie recenti che menzionano questa società

23

Evidenze della Chiamata degli Utassi di Haemonetics Q4 Yahoo Finance · 4 mesi, 3 settimane fa La strategia Riverwater Sustainable Value attende la validazione del mercato di Haemonetics Corporation (HAE) Yahoo Finance · 5 mesi, 2 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

HAE Haemonetics Corporation Common Stock

HAE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

HAE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Informazioni su Haemonetics Corporation Common Stock Panoramica della società da Wikipedia

History

Product categories

Hemostasis

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Proprietari istituzionali (13F) 361 filer · $4.0B totale · Aggiornato al 30 Settembre 2026

Attivisti e proprietari del 5%+ 8 partecipazioni

Insider aziendali 72 insider · 48 dirigenti · 25 direttori

Proprietà ETF Posseduti da 65 ETF

HAE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi